scholarly article | Q13442814 |
P50 | author | Diego Arango | Q38642741 |
John M Mariadason | Q60960610 | ||
P2093 | author name string | Chang Tong | |
Leonard H Augenlicht | |||
Wancai Yang | |||
Min Zhuang | |||
Maomi Li | |||
Tianhong Li | |||
Do-Sun Byun | |||
Shannon Nasser | |||
P2860 | cites work | Biphasic increase of apical Cl− conductance by muscarinic stimulation of ht-29cl.19a human colon carcinoma cell line: Evidence for activation of different cl− conductances by carbachol and forskolin | Q41633293 |
A mucus-secreting human colonic cancer cell line. Purification and partial characterization of the secreted mucins | Q42835780 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
P304 | page(s) | 1289-1299 | |
P577 | publication date | 2008-11-01 | |
P1433 | published in | Molecular Nutrition and Food Research | Q15751861 |
P1476 | title | Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer | |
P478 | volume | 52 |
Q90310127 | A Caenorhabditis elegans ortholog of human selenium-binding protein 1 is a pro-aging factor protecting against selenite toxicity |
Q36324749 | A Critical Role for Cysteine 57 in the Biological Functions of Selenium Binding Protein-1. |
Q37597313 | A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis |
Q41170872 | ATF3 suppresses ESCC via downregulation of ID1. |
Q84245713 | Altered expression of selenium-binding protein 1 in gastric carcinoma and precursor lesions |
Q28541543 | Applying of hierarchical clustering to analysis of protein patterns in the human cancer-associated liver |
Q34193882 | Decreased selenium-binding protein 1 in esophageal adenocarcinoma results from posttranscriptional and epigenetic regulation and affects chemosensitivity |
Q34250582 | Decreased selenium-binding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma |
Q35997645 | Distribution and inhibition effect of Seleno-L-Methionine on 4T1 mouse mammary carcinoma |
Q41493120 | Does aberrant membrane transport contribute to poor outcome in adult acute myeloid leukemia? |
Q35069680 | Downregulation of cellular protective factors of rumen epithelium in goats fed high energy diet |
Q35067875 | EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy |
Q34000677 | Elevated expression of SLC34A2 inhibits the viability and invasion of A549 cells |
Q28547310 | Evidence that selenium binding protein 1 is a tumor suppressor in prostate cancer |
Q34042351 | Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein |
Q24313015 | Human selenium binding protein-1 (hSP56) interacts with VDU1 in a selenium-dependent manner |
Q38990401 | Human selenium binding protein-1 (hSP56) is a negative regulator of HIF-1α and suppresses the malignant characteristics of prostate cancer cells |
Q42032848 | Hypoxia-inducible factor-1alpha suppresses squamous carcinogenic progression and epithelial-mesenchymal transition |
Q34571042 | Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS. |
Q42632704 | Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue |
Q38097279 | Is selenium a potential treatment for cancer metastasis? |
Q36073942 | Loss of Selenium-Binding Protein 1 Decreases Sensitivity to Clastogens and Intracellular Selenium Content in HeLa Cells |
Q27011247 | Molecular cross-talk between members of distinct families of selenium containing proteins |
Q37392350 | Molecular mechanisms by which selenoproteins affect cancer risk and progression |
Q34618992 | Proteomic analysis of differentially expressed proteins in peripheral cholangiocarcinoma |
Q36142004 | Quantitative proteome analysis of colorectal cancer-related differential proteins |
Q35606645 | Quantitative proteomic analysis reveals that anti-cancer effects of selenium-binding protein 1 in vivo are associated with metabolic pathways |
Q34737626 | Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium |
Q54434422 | Reduced selenium-binding protein 1 is associated with poor survival rate in gastric carcinoma. |
Q38201580 | Selenium and selenoproteins in inflammatory bowel diseases and experimental colitis |
Q40428099 | Selenium-Binding Protein 1 (SBP1) autoantibodies in ovarian disorders and ovarian cancer |
Q59792718 | Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes |
Q37249829 | Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome |
Q51740537 | Selenium-binding protein 1 is down-regulated in malignant melanoma. |
Q92523385 | Selenium-binding protein 1 transcriptionally activates p21 expression via p53-independent mechanism and its frequent reduction associates with poor prognosis in bladder cancer |
Q28535416 | The function and significance of SELENBP1 downregulation in human bronchial epithelial carcinogenic process |
Q36945715 | Toward understanding success and failures in the use of selenium for cancer prevention |
Q30896473 | Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts |